A non-randomised controlled pilot study of clinical pharmacist collaborative intervention for community dwelling patients with COPD.

ABSTRACT: UK, home-based patients with COPD receive specialist care from respiratory physicians, nurses, and general practitioners (GPs), but increasing complexity of therapeutic options and a GP/Nurse workforce crisis suggests merit in testing the role of home visits by a clinical pharmacist. We conducted a non-randomised intervention study with a contemporaneous comparator group, in Glasgow (Scotland). A clinical pharmacist (working closely with a consultant respiratory physician) visited patients with COPD living at home, assessing respiratory and other co-morbid conditions, and medicines then, with patient approval, agreed treatment modifications with a consultant physician. Comparator group-patients were drawn from another hospital out-patient clinic. Main outcomes were exacerbations during 4-m

SUBMITTER: Hunt V 

PROVIDER: S-EPMC6180130 | biostudies-literature | 2018 Oct

REPOSITORIES: biostudies-literature